Hancom MDS Inc Capital Reinvestment Ratio
Hancom MDS Inc capital reinvestment ratio. Hancom MDS Inc (086960) has a Capital Reinvestment Ratio of 0.27x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩6.11 Billion) in capital expenditures (₩1.65 Billion). Check Hancom MDS Inc (086960) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Hancom MDS Inc (2007–2025)
Capital reinvestment ratio of Hancom MDS Inc from 2007 to 2025. This chart tracks Hancom MDS Inc's Capital Reinvestment Ratio across 14 annual periods. Also explore 086960 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Hancom MDS Inc Capital Reinvestment Ratio by Year (2007–2025)
Hancom MDS Inc capital reinvestment ratio by year from 2007 to 2025. For the full cash flow conversion analysis, see cash flow conversion of Hancom MDS Inc.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | ₩16.12 Billion | ₩4.04 Billion | ▼ -48.8% |
| 2024 | 0.49x | ₩2.90 Billion | ₩1.42 Billion | ▲ +1514.7% |
| 2023 | 0.03x | ₩26.32 Billion | ₩798.10 Million | ▼ -93.2% |
| 2021 | 0.45x | ₩2.83 Billion | ₩1.27 Billion | ▲ +22.0% |
| 2020 | 0.37x | ₩6.78 Billion | ₩2.48 Billion | ▼ -17.7% |
| 2019 | 0.44x | ₩4.95 Billion | ₩2.20 Billion | ▲ +146.7% |
| 2018 | 0.18x | ₩20.47 Billion | ₩3.69 Billion | ▼ -45.1% |
| 2017 | 0.33x | ₩3.57 Billion | ₩1.17 Billion | ▼ -54.3% |
| 2015 | 0.72x | ₩6.27 Billion | ₩4.50 Billion | ▲ +393.2% |
| 2014 | 0.15x | ₩12.73 Billion | ₩1.85 Billion | ▼ -45.1% |
| 2013 | 0.27x | ₩12.06 Billion | ₩3.20 Billion | ▼ -71.4% |
| 2012 | 0.93x | ₩6.63 Billion | ₩6.17 Billion | ▲ +563.2% |
| 2011 | 0.14x | ₩4.76 Billion | ₩667.39 Million | ▲ +4.5% |
| 2007 | 0.13x | ₩7.05 Billion | ₩946.15 Million | — |